Latest Breaking News On - Bio science group limited - Page 4 : comparemela.com

Uni-Bio Science Group Limited: 2022 Interim -2-

DJ Uni-Bio Science Group Limited: 2022 Interim Results EQS Newswire / 29/08/2022 / 19:21 UTC+8 2022 Interim Results Pinup® and Boshutai® Generated Remarkable Turnover while Achieving

Hong kongKostenloser wertpapierhandelKingsley leungChina national medical products administrationBio science groupFinancial pressGroup acarbose tablets boshutaiBio science group limited uniBio science group limitedGenerated remarkable turnoverAchieving record high profitHighly commercial drivenSpecialized rd platformFirst halfAcarbose tabletsHenan thirteen provinces allianceprocurement

Uni-Bio Science Group Limited: 2022 Interim Results | Taiwan News

Uni-Bio Science Group Limited: 2022 Interim Results | 2022-08-29 20:40:00

Hong kongKingsley leungChina national medical products administrationBio science groupHenan thirteen provinces alliance procurementGroup acarbose tablets boshutaiBio science group limited uniGenerated remarkable turnoverAchieving record high profitaimHighly commercial drivenUni bio science group limitedFirst halfAcarbose tabletsHong kong science parkUni bio scienceGlobal cosmetic

Uni-Bio Science Group Limited: 2022 Interim Results

Uni-Bio Science Group Limited: 2022 Interim Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Hong kongKostenloser wertpapierhandelKingsley leungChina national medical products administrationBio science groupGroup acarbose tablets boshutaiBio science group limited uniBio science group limitedGenerated remarkable turnoverAchieving record high profitHighly commercial drivenSpecialized rd platformFirst halfAcarbose tabletsHenan thirteen provinces allianceprocurementHong kong science park

Marketing application of BOGUTAI® (teriparatide injection) has been officially accepted by the China

EQS-News / 29/06/2022 / 09:00 UTC+8 Marketing application of BOGUTAI® (teriparatide injection) has been officially accepted by the China National Medical Products Administration (NMPA)[28 June 2022 – Hong Kong] A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (the “Company”, together.

Marketing pressChina national medical products administrationBio science groupBio science group limited the companyUni bio science group limitedBio science group limitedUni bio science groupMarketing press release

Uni Bio Science : opens Hong Kong research centre,Future R&D focus in four major businesses

【For Immediate Release】 13 June 2022 . | June 13, 2022

New territoriesHong kong generalHong kongUniversity of hong kongHenan thirteen provinces allianceBio science groupChinese university of hong kongBio science group limited the companyFor immediate releaseStock codeBio science group limitedHong kong science parkAcarbose tabletsUni bio science group limitedPark east avenueVoriconazole tablets